<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">842238</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2022.842238</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Assembly of a Library of Pel-Oligosaccharides Featuring <italic>&#x3b1;</italic>-Glucosamine and <italic>&#x3b1;</italic>-Galactosamine Linkages</article-title>
<alt-title alt-title-type="left-running-head">Zhang et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Assembly of Pel-Oligosaccharides</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yongzhen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Liming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1624095/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Overkleeft</surname>
<given-names>Herman S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van der Marel</surname>
<given-names>Gijsbert A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cod&#xe9;e</surname>
<given-names>Jeroen D. C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/774545/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Chemistry</institution>, <institution>Leiden University</institution>, <addr-line>Leiden</addr-line>, <country>Netherlands</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>National Research Centre for Carbohydrate Synthesis</institution>, <institution>Jiangxi Normal University</institution>, <addr-line>Nanchang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1433821/overview">M. Carmen Galan</ext-link>, University of Bristol, United&#x20;Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/445908/overview">Antonio Molinaro</ext-link>, University of Naples Federico II, Italy</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/124126/overview">Todd Lowary</ext-link>, University of Alberta, Canada</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jeroen D. C. Cod&#xe9;e, <email>jcodee@chem.leidenuniv.nl</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Organic Chemistry, a section of the journal Frontiers in Chemistry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>842238</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhang, Wang, Overkleeft, van der Marel and Cod&#xe9;e.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhang, Wang, Overkleeft, van der Marel and Cod&#xe9;e</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>
<italic>Pseudomonas aeruginosa</italic>, a pathogenic Gram-negative bacterium for which currently antibiotic resistance is posing a significant problem and for which no vaccines are available, protects itself by the formation of a biofilm. The Pel polysaccharide, a cationic polymer composed of <italic>cis</italic>-linked galactosamine (GalN), <italic>N</italic>-acetyl galactosamine (GalNAc), glucosamine (GlcN) and <italic>N</italic>-acetyl glucosamine (GlcNAc) monosaccharides, is an important constituent of the biofilm. Well-defined Pel oligosaccharides will be valuable tools to probe the biosynthesis machinery of this polysaccharide and may serve as diagnostic tools or be used as components of glycoconjugate vaccines. We here, report on the development of synthetic chemistry to access well-defined Pel-oligosaccharides. The chemistry hinges on the use of di-<italic>tert</italic>-butylsilylidene protected GalN and GlcN building blocks, which allow for completely <italic>cis</italic>-selective glycosylation reactions. We show the applicability of the chemistry by the assembly of a matrix of 3&#x20;&#xd7; 6 Pel heptasaccharides, which has been generated from a single set of suitably protected Pel heptasaccharides, in which a single glucosamine residue is incorporated and positioned at different places along the Pel oligo-galactosamine&#x20;chain.</p>
</abstract>
<kwd-group>
<kwd>glycosylation</kwd>
<kwd>sereoselectivity</kwd>
<kwd>bacterial polysaccharides</kwd>
<kwd>
<italic>pseudomonas aeruginosa</italic>
</kwd>
<kwd>biofilm</kwd>
</kwd-group>
<contract-num rid="cn001">726072</contract-num>
<contract-sponsor id="cn001">European Research Council<named-content content-type="fundref-id">10.13039/501100000781</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>
<italic>Pseudomonas aeruginosa</italic> is an opportunistic Gram-negative pathogen that can cause both acute and chronic infections in immunocompromised patients (<xref ref-type="bibr" rid="B7">Franklin et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B9">Ghafoor et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B20">Ma et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B15">Jennings et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B22">Marmont et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B32">Whitfield et&#x20;al., 2020</xref>). <italic>P. aeruginosa</italic> can become resistant to antibiotics due to its ability to form a biofilm which complicates the treatment of its infections. As part of the biofilm three exopolysaccharides are synthesized, alginate, Pel and Psl (<xref ref-type="bibr" rid="B7">Franklin et&#x20;al., 2011</xref>). Alginate is a negatively charged polymer of mannuronic and guluronic acid (<xref ref-type="bibr" rid="B6">Flo et&#x20;al., 2002</xref>), while Psl is a neutral polysaccharide composed of a pentasaccharide repeat containing glucose, rhamnose and mannose (<xref ref-type="bibr" rid="B14">Jackson et&#x20;al., 2004</xref>). Pel is a positively charged polymer, and although its structure has not been fully characterized it is thought to be composed of <italic>&#x3b1;</italic>-1,4-linked <italic>N</italic>-acetylgalactosamine (GalNAc) and <italic>N</italic>-acetyl-glucosamine (GlcNAc), both of which can be de-acetylated to give galactosamine (GalN) and glucosamine (GlcN) residues, respectively (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). The GalN(Ac): GlcN(Ac) ratio has been reported to be &#xb1;6:1 (<xref ref-type="bibr" rid="B15">Jennings et&#x20;al., 2015</xref>). Pel plays an important role in maintaining cell-cell interactions in biofilms and affords protection to the bacterium by enhancing resistance to aminoglycoside antibiotics (<xref ref-type="bibr" rid="B5">Colvin et&#x20;al., 2011</xref>). Well-defined fragments of the Pel polymer can serve as powerful research tools in various interconnected fields of research. They may serve as synthetic antigens in the generation of potential <italic>pseudomonas</italic> vaccines and they can be used in elucidating biosynthesis pathways and characterizing the enzymes involved therein. This may open up avenues to interfere with the biosynthesis and eventually generate anti-bacterial compounds. Because of the seemingly random distribution of monosaccharides in Pel, it is impossible to isolate well defined fragments from natural sources and therefore organic synthesis is the method of choice to provide&#x20;these.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(A)</bold> Structure of Pel. <bold>(B)</bold> Structures of designed Pel oligomers.</p>
</caption>
<graphic xlink:href="fchem-10-842238-g001.tif"/>
</fig>
<p>The key to the assembly of Pel fragments is the stereoselective introduction of <italic>&#x3b1;</italic>-GalN, <italic>&#x3b1;</italic>-GalNAc, <italic>&#x3b1;</italic>-GlcN and <italic>&#x3b1;</italic>-GlcNAc linkages. We have previously described the successful application of the 4,6-<italic>O</italic>-di-<italic>tert</italic>-butylsilylidene (DTBS) directed <italic>&#x3b1;</italic>-galactosylation methodology, developed by Kiso&#x2019;s group (<xref ref-type="bibr" rid="B11">Imamura et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B10">Imamura et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B27">Sato et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B12">Imamura et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B16">Kazakova et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B30">Wang et&#x20;al., 2020</xref>), for the synthesis of the structurally related galactosaminogalactan (GAG) homo- and hetero-oligosaccharides that occur in the cell wall of <italic>Aspergillus fumigatus</italic> and that are composed of 1,4-linked <italic>&#x3b1;</italic>-Gal, <italic>&#x3b1;</italic>-GalN, <italic>&#x3b1;</italic>-GalNAc residues (<xref ref-type="bibr" rid="B1">Bamford et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B17">Le Mauff et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B2">Bamford et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B35">Zhang et&#x20;al., 2020a</xref>). The application of 4,6-<italic>O</italic>-DTBS protected GalN<sub>3</sub> and GalNHTCA donors resulted in glycosylations with high <italic>&#x3b1;</italic>-stereoselectivity to give a row of GAG fragments, having both GalN and GalNAc constituents. The high <italic>&#x3b1;</italic>-stereoselectivity of the glycosylations proved to be insensitive to the nature of the C-2-<italic>N</italic>-acyl group, capable of neighboring group participation. On the basis of these results, we selected DTBS-protected GalN donors as building blocks for the construction of <italic>&#x3b1;</italic>-GalN and <italic>&#x3b1;</italic>-GalNAc linkages in Pel. The formation of similar <italic>&#x3b1;</italic>-GlcN linkages is more challenging and substantial effort has been expended to develop a procedure for the stereoselective introduction of <italic>&#x3b1;</italic>-GlcN linkages (<xref ref-type="bibr" rid="B3">Benakli et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B31">Wei and Kerns, 2005</xref>; <xref ref-type="bibr" rid="B21">Manabe et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B25">Park et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B8">Geng et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B24">Olsson et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B23">Mensah et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B33">Ye and Geng, 2010</xref>; <xref ref-type="bibr" rid="B13">Ingle et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B28">van der Vorm et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B36">Zhang et&#x20;al., 2020</xref>). Recently, we have reported on an effective synthetic strategy to assemble a Pel-type oligosaccharide, containing 1,4-linked GalNAc and GlcNAc residues (<xref ref-type="bibr" rid="B30">Wang et&#x20;al., 2020</xref>). A [2 &#x2b; 2&#x20;&#x2b; 2] strategy was developed for the synthesis of a hexasaccharide in which the glucosamine linkages were constructed using a <italic>N</italic>-methyl-<italic>N</italic>-phenylformamide (MPF)-modulated glycosylation methodology. We have previously also systematically evaluated a set of glycosylation reactions between a series of 4,6-tethered glucosazide donors and a panel of acceptors to find that with increasing reactivity of the studied GlcN<sub>3</sub>-donors and decreasing nucleophilicity of the acceptors, the <italic>&#x3b1;</italic>-selectivity of the glycosylations increased (<xref ref-type="bibr" rid="B28">van der Vorm et&#x20;al., 2017</xref>). The most reactive GlcN<sub>3</sub> donor that was studied carried a 4,6-DTBS group and its reaction with the model nucleophile trifluoroethanol (TFE) gave the <italic>&#x3b1;</italic>-linked product exclusively. As the nucleophilicity of the C-4-OH in GalN moieties is relatively low, the DTBS-GlcN<sub>3</sub> donors may represent promising building blocks for the construction of <italic>&#x3b1;</italic>-GlcN-(1&#x2192;4)-GalN linkages.</p>
<p>We here describe the synthesis of a library of Pel fragments with DTBS-directed glycosylation methodology. A library of hetero-oligomers containing <italic>&#x3b1;</italic>-GalN/<italic>&#x3b1;</italic>-GalNAc and <italic>&#x3b1;</italic>-GlcN/<italic>&#x3b1;</italic>-GlcNAc residues at predetermined positions, was designed (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>). A set of heptamers, each of which contains one GlcN/GlcNAc-residue and six GalN/GalNAc residues, was selected because of the GalNAc:GlcNAc ratio that is present in naturally occurring Pel polysaccharides, while some of the residues have been deacetylated (<xref ref-type="bibr" rid="B15">Jennings et&#x20;al., 2015</xref>). Also a spacer was incorporated at the reducing end of the heptamers for future conjugation purposes.</p>
</sec>
<sec sec-type="results|discussion" id="s2">
<title>Results and Discussion</title>
<p>As the DTBS-directed <italic>&#x3b1;</italic>-galactosylation methodology is well established, attention was first paid to the formation of <italic>&#x3b1;</italic>-GlcN<sub>3</sub>-(1&#x2192;4)-GalN<sub>3</sub> linkages. A set of glycosylation reactions was investigated using GlcN<sub>3</sub> donors <bold>1&#x2013;4</bold> (<xref ref-type="bibr" rid="B28">van der Vorm et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B26">Revuelta et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B29">Wang et&#x20;al., 2018</xref>) and GalN<sub>3</sub> acceptors <bold>5&#x2013;7</bold> (<xref ref-type="bibr" rid="B30">Wang et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B35">Zhang et&#x20;al., 2020a</xref>) (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). First, the additive <italic>N</italic>-methyl-<italic>N</italic>-phenylformamide (MPF) controlled <italic>&#x3b1;</italic>-glycosylation methodology was attempted to introduce the <italic>&#x3b1;</italic>-GlcN linkage. With this methodology, glycosylation of benzylated GlcN<sub>3</sub> donor <bold>1</bold> with benzylated GalN<sub>3</sub> acceptor <bold>7</bold> led to the disaccharide <bold>8</bold> with 7:1&#x20;<italic>&#x3b1;</italic>/<italic>&#x3b2;</italic>-selectivity, but the yield was only 47% (<xref ref-type="table" rid="T1">Table&#x20;1</xref>, entry 1). Using the same conditions, coupling of 4,6-DTBS-protected GlcN<sub>3</sub> donor <bold>4</bold> with GalN<sub>3</sub> <bold>7</bold> afforded the dimer in a mere 5% yield (entry 2), owing to the low reactivity of the GalN<sub>3</sub> C4-OH acceptor. Next, a pre-activation strategy, using GlcN<sub>3</sub> donors <bold>2</bold> and <bold>3</bold> as donors was explored. Benzylidene-protected donor <bold>2</bold> reacted with acceptor <bold>5</bold>, to afford disaccharide <bold>9</bold> in 38% yield and with a 3.5/1&#x20;<italic>&#x3b1;</italic>/<italic>&#x3b2;</italic> ratio (entry 3). When the more reactive DTBS-protected donor <bold>3</bold> was treated with <bold>5</bold>, a slightly better <italic>&#x3b1;</italic>-selectivity was obtained (<italic>&#x3b1;</italic>/<italic>&#x3b2;</italic> &#x3d; 5/1, entry 4). Condensation of donor <bold>3</bold> with 6-O-Bn protected acceptor <bold>6</bold> led to <bold>11</bold> (<xref ref-type="bibr" rid="B30">Wang et&#x20;al., 2020</xref>) in excellent yield and <italic>&#x3b1;</italic>-selectivity (entry 5). By contrast, changing the linker of the acceptor to 3-buten-ol, which is more convenient for future conjugation purposes, gave no glycosylation product (entry 6). Condensation of GlcN<sub>3</sub> donor <bold>3</bold> and acceptor <bold>7</bold>, promoted by NIS and TfOH at &#x2212;40&#xb0;C, also failed to afford the product (entry 7). To further improve the reaction, imidate donor <bold>4</bold> was coupled with acceptor <bold>5</bold>, under influence of TBSOTf, giving dimer <bold>10</bold> with moderate <italic>&#x3b1;</italic>-selectivity (<italic>&#x3b1;</italic>/<italic>&#x3b2;</italic> &#x3d; 3.7/1, entry 8). Gratifyingly, performing the glycosylation of donor <bold>4</bold> and acceptor <bold>7</bold>, at &#x2212;10&#xb0;C with TfOH as promotor, furnished the desired disaccharide <bold>12</bold> in 77% yield with excellent <italic>&#x3b1;</italic>-selectivity (&#x3e;20:1, entry 9). Based on these model reactions, the DTBS-tethered GlcN<sub>3</sub> donor <bold>4</bold> was chosen for the construction of <italic>&#x3b1;</italic>-GlcN<sub>3</sub>-(1&#x2192;4)-GalN<sub>3</sub> linkages, and the benzyl group was preferred for the protection of C6-OH of the GalN acceptors. Notably, the implementation of this strategy would match exceptionally well with the strategy we previously developed for the introduction of <italic>&#x3b1;</italic>-GalN and <italic>&#x3b1;</italic>-GalNAc linkages in the synthesis of the related GAG oligosaccharides.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Glycosylation between GlcN<sub>3</sub> donors and GalN<sub>3</sub> acceptors.</p>
</caption>
<table>
<tbody>
<tr>
<td>
<inline-graphic xlink:href="fchem-10-842238-fx1.tif"/>
</td>
</tr>
</tbody>
</table>
<table>
<thead valign="top">
<tr>
<th align="left">Entry</th>
<th align="center">Donor</th>
<th align="center">Acceptor</th>
<th align="center">Reagents and conditions</th>
<th align="center">Temperature</th>
<th align="center">Product</th>
<th align="center">
<italic>&#x3b1;</italic>/<italic>&#x3b2;</italic>
</th>
<th align="center">Yield</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="center">
<bold>1</bold>
</td>
<td align="center">
<bold>7</bold>
</td>
<td align="center">TfOH, MPF, DCM</td>
<td align="center">&#x2212;78 to 0&#xb0;C</td>
<td align="center">
<bold>8</bold>
</td>
<td align="char" char="/">7/1</td>
<td align="center">47%</td>
</tr>
<tr>
<td align="left">2</td>
<td align="center">
<bold>4</bold>
</td>
<td align="left"/>
<td align="left"/>
<td align="center">&#x2212;78 to 0&#xb0;C</td>
<td align="center">
<bold>12</bold>
</td>
<td align="char" char="/">&#x3e;10/1</td>
<td align="center">5%</td>
</tr>
<tr>
<td align="left">3</td>
<td align="center">
<bold>2</bold>
</td>
<td align="center">
<bold>5</bold>
</td>
<td rowspan="4" align="center">Tf<sub>2</sub>O, Ph<sub>2</sub>SO, TTBP, DCM</td>
<td align="center">&#x2212;78 to &#x2212;40&#xb0;C</td>
<td align="center">
<bold>9</bold>
</td>
<td align="char" char="/">3.5/1</td>
<td align="center">38%</td>
</tr>
<tr>
<td align="left">4</td>
<td rowspan="3" align="center">
<bold>3</bold>
</td>
<td align="center">
<bold>5</bold>
</td>
<td align="center">&#x2212;40&#xb0;C</td>
<td align="center">
<bold>10</bold>
</td>
<td align="char" char="/">5/1</td>
<td align="center">65%</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">
<bold>6</bold>
</td>
<td align="center">&#x2212;40&#xb0;C</td>
<td align="center">
<bold>11</bold>
</td>
<td align="char" char="/">13/1</td>
<td align="center">81%</td>
</tr>
<tr>
<td align="left">6</td>
<td align="center">
<bold>7</bold>
</td>
<td align="center">&#x2212;40&#xb0;C</td>
<td align="center">
<bold>12</bold>
</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">7</td>
<td align="center">
<bold>3</bold>
</td>
<td align="center">
<bold>7</bold>
</td>
<td align="center">NIS, TfOH, DCM</td>
<td align="center">&#x2212;40 to 0&#xb0;C</td>
<td align="center">
<bold>12</bold>
</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">8</td>
<td rowspan="2" align="center">
<bold>4</bold>
</td>
<td align="center">
<bold>5</bold>
</td>
<td align="center">TBSOTf, DCM</td>
<td align="center">&#x2212;78 to &#x2212;40&#xb0;C</td>
<td align="center">
<bold>10</bold>
</td>
<td align="char" char="/">3.7/1</td>
<td align="center">62%</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">
<bold>7</bold>
</td>
<td align="center">TfOH, DCM</td>
<td align="center">&#x2212;10&#xb0;C</td>
<td align="center">
<bold>12</bold>
</td>
<td align="char" char="/">&#x3e;20/1</td>
<td align="center">77%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The bold numbers are the sequence numbers of compounds.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>With conditions in hand to construct the required <italic>&#x3b1;</italic>-GalN and <italic>&#x3b1;</italic>-GlcN linkages, attention was directed to the assembly of a library of Pel heptamers, consisting of (3 &#xd7; 6) members, that can be achieved by the synthesis of six protected heptameric precursors and subjecting these to different deprotection procedures. The projected eighteen heptamers contain one GlcN or GlcNAc, differently positioned in the heptameric chain, while the remaining residues are all GalN, all GalNAc or alternating GalN and GalNAc (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>). The retrosynthesis of Pel heptamers <bold>A&#x2013;C</bold> with either GlcN or GlcNAc at the second position from the reducing end of the heptamer is depicted in <xref ref-type="fig" rid="F2">Figure&#x20;2</xref>. This retrosynthesis also applies to the remaining members of the projected library that can be accessed using the same strategy. The deprotected heptamers <bold>A&#x2013;C</bold> are derived from protected heptamer <bold>D</bold> through different procedures for the removal of the protecting groups. In path a, the sequence of deprotection steps include DTBS removal, reduction of azido groups, and removal of Bn and TFA groups via Birch reduction to afford compound <bold>A</bold>, containing GalN and GlcN residues. Birch reduction is chosen to avoid reduction of C-C double bond in the linker (<xref ref-type="bibr" rid="B34">Zhang et&#x20;al., 2019</xref>). Acetylation of free amine groups in <bold>A</bold> can furnish heptamer <bold>B</bold>. In path b, the C2-<italic>N</italic>-TFA groups are first removed, followed by desilylation and acetylation of the released amino groups, after which reduction the azido and Bn-groups should give the heptamer <bold>C</bold>. The common protected heptamer <bold>D</bold> can be constructed with GlcN<sub>3</sub> donor <bold>4</bold>, GalN<sub>3</sub> donor <bold>13</bold> and GalNHTFA donor <bold>14</bold>, which would serve as precursors for the GlcN, GlcNAc, GalN and GalNAc residues.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Retrosynthetic analysis of Pel heptasaccharides.</p>
</caption>
<graphic xlink:href="fchem-10-842238-g002.tif"/>
</fig>
<p>
<xref ref-type="table" rid="T2">Table&#x20;2</xref> summarizes the syntheses of the six fully protected Pel heptasaccharides (<bold>20</bold>, <bold>26</bold>, <bold>31</bold>, <bold>35</bold>, <bold>38</bold>, <bold>40</bold>) with one GlcN<sub>3</sub> residue at different positions. The elongation cycle consisted of the following three-steps: 1) Glycosylation using the donor of choice, 2) DTBS-removal with HF/pyridine and 3) selective benzylation of the primary alcohol group. The Bn group can be regioselectively introduced under the aegis of Taylor&#x2019;s borinic acid catalyst (<xref ref-type="bibr" rid="B4">Chan and Taylor, 2011</xref>; <xref ref-type="bibr" rid="B18">Lee and Taylor, 2011</xref>; <xref ref-type="bibr" rid="B19">Lee et&#x20;al., 2012</xref>). As can be seen from the Table, the heptasaccharide <bold>20</bold> (or <bold>D</bold> in <xref ref-type="fig" rid="F2">Figure&#x20;2</xref>) with the GlcN<sub>3</sub> moiety at the second position from the reducing end of the heptamer was first synthesized. Condensation of GlcN<sub>3</sub> donor <bold>4</bold> and acceptor <bold>7</bold> led to the disaccharide <bold>12</bold> using a TfOH promoted condensation at &#x2212;10&#xb0;C (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). Next the DTBS group was cleaved and the liberated 6-OH was benzylated selectively to form the desired 4-OH acceptor, which was reacted with GalNHTFA donor <bold>14</bold> giving the trisaccharide <bold>16</bold> in 73% yield over the three steps. However, the relatively moderate yield of the glycosylation for the tetra- and pentamer (56% for <bold>17</bold> and 51% for <bold>18</bold>) was an incentive to optimize the glycosylation reaction conditions. It was found that implementation of a &#x201c;reverse addition sequence&#x201d; strategy, in which the acceptor and activator are mixed, after which the donor is slowly added, greatly improved the reaction yields (71% for <bold>17</bold> and 72% for <bold>18</bold>). Elongation of the pentamer with another copy of the GalN<sub>3</sub> donor <bold>13</bold> and subsequently the GalNHTFA building block <bold>14</bold>, delivered heptasaccharide <bold>20</bold> in excellent yields. It should be noted that the desilylation reactions and regioselective benzylations all occurred with excellent chemo- and regioselectivity, showing the effectivity of these reactions to be independent on glycan length.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Synthesis of Pel oligomers.</p>
</caption>
<table>
<tbody>
<tr>
<td>
<inline-graphic xlink:href="fchem-10-842238-fx2.tif"/>
</td>
</tr>
</tbody>
</table>
<table>
<thead valign="top">
<tr>
<th align="left">
<italic>n</italic>
</th>
<th align="center">(GluR)<sub>m</sub> GalN<sub>3</sub>
</th>
<th align="center">Yield<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn8">
<sup>h</sup>
</xref>
<sup>]</sup>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">2</td>
<td align="left">GlcN<sub>3</sub> GalN<sub>3</sub>
</td>
<td align="center">
<bold>12</bold> (71%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub>
</td>
<td align="center">
<bold>16</bold> (73%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn5">
<sup>e</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">GalN<sub>3</sub> GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub>
</td>
<td align="center">
<bold>17</bold> (56%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn4">
<sup>d</sup>
</xref>
<sup>]</sup> (71%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">GalNHTFA GalN<sub>3</sub> GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub>
</td>
<td align="center">
<bold>18</bold> (51%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn5">
<sup>e</sup>
</xref>
<sup>)</sup> (72%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub>
</td>
<td align="center">
<bold>19</bold> (69%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub>
</td>
<td align="center">
<bold>20</bold> (67%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>21</bold> (79%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn5">
<sup>e</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>22</bold> (74%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">GalN<sub>3</sub> GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>23</bold> (68%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">GalNHTFA GalN<sub>3</sub> GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>24</bold> (78%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>25</bold> (68%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>26</bold> (76%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>27</bold> (79%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">GlcN<sub>3</sub> GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>28</bold> (73%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>29</bold> (70%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">GalN<sub>3</sub> GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>30</bold> (73%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">GalNHTFA GalN<sub>3</sub> GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>31</bold> (74%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>32</bold> (66%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>33</bold> (74%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">GalN<sub>3</sub> GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>34</bold> (56%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">GalNHTFA GalN<sub>3</sub> GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>35</bold> (52%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>36</bold> (74%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">GlcN<sub>3</sub> GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>37</bold> (77%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">GalNHTFA GlcN<sub>3</sub> GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>38</bold> (50%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>39</bold> (67%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn7">
<sup>g</sup>
</xref>
<sup>)</sup>
</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">GlcN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub> GalNHTFA GalN<sub>3</sub>
</td>
<td align="center">
<bold>40</bold> (60%)<sup>(</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
<sup>)</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>HF/pyridine, THF, 0&#xb0;C to&#x20;rt.</p>
</fn>
<fn id="Tfn2">
<label>b</label>
<p>Ph<sub>2</sub>BO(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub>, KI, K<sub>2</sub>CO<sub>3</sub>, BnBr, MeCN, 60&#xb0;C.</p>
</fn>
<fn id="Tfn3">
<label>c</label>
<p>
<bold>4</bold>, TfOH, 4&#xc5;&#xa0;MS, DCM, &#x2212;10&#xb0;C.</p>
</fn>
<fn id="Tfn4">
<label>d</label>
<p>
<bold>13</bold>, TfOH, 4&#xc5;&#xa0;MS, DCM, 0&#xb0;C.</p>
</fn>
<fn id="Tfn5">
<label>e</label>
<p>
<bold>14</bold>, TfOH, 4&#xc5;&#xa0;MS, DCM, 0&#xb0;C.</p>
</fn>
<fn id="Tfn6">
<label>f</label>
<p>TfOH, 4&#xc5;&#xa0;MS, DCM, then <bold>13</bold> added in 1&#xa0;h, 0&#xb0;C for 3, 4 and 5-mers, &#x2212;20&#xb0;C for 6 and 7-mers.</p>
</fn>
<fn id="Tfn7">
<label>g</label>
<p>TfOH, 4&#xc5;&#xa0;MS, DCM, then <bold>14</bold> added in 1&#xa0;h, 0&#xb0;C for 4 and 5-mers, &#x2212;20&#xb0;C for 6 and 7-mers.</p>
</fn>
<fn id="Tfn8">
<label>h</label>
<p>yields for over three&#x20;steps.</p>
</fn>
<fn id="Tfn9">
<label>i</label>
<p>The bold numbers are the sequence numbers of compounds.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In an analogous way, the assembly of target heptasaccharides <bold>26</bold>, <bold>31</bold>, <bold>35</bold>, <bold>38</bold>, and <bold>40</bold> with a GlcN<sub>3</sub> moiety at the positions 3-7 was accomplished with building blocks <bold>4</bold>, <bold>13</bold> and <bold>14</bold>. Repetition of the elongation cycle, comprising the same three steps as described above led to all target heptasaccharides. The glycosylation reactions proceeded efficiently providing the intermediate and target oligosaccharides (<italic>n</italic>&#x20;&#x3d; 2&#x2013;7) with excellent stereoselectivity and good yields (50&#x2013;79% yields for three steps). The mixed sequence structures were generated uneventfully, showing the chemistry developed to be applicable to any type of Pel-target.</p>
<p>With all six protected heptasaccharides in hand, deprotection conditions were explored to complete the assembly of all projected Pel oligomers (<xref ref-type="fig" rid="F3">Scheme 1</xref>). First, the set of 7-mers containing solely <italic>&#x3b1;</italic>-GalN and <italic>&#x3b1;</italic>-GlcN moieties was generated. Removal of the DTBS-group in heptamers <bold>20</bold>, <bold>26</bold>, <bold>31</bold>, <bold>35</bold>, <bold>38</bold> and&#x20;<bold>40</bold> was performed with HF/pyridine and the azido-groups&#x20;could be reduced with HS(CH<sub>2</sub>)<sub>3</sub>SH, after which the Bn groups together with the TFA groups were cleaved using sodium in ammonia and THF, affording the 7-mers <bold>41&#x2013;46</bold> in 48&#x2013;85% yields. In the Birch reduction, allyl carbinol was used as a scavenger to prevent reduction of the linker alkene. A portion of the 7-mers <bold>41&#x2013;46</bold> was chemoselectively acetylated to provide the second set of heptamers <bold>47&#x2013;52</bold>, composed of <italic>&#x3b1;</italic>-GalNAc and <italic>&#x3b1;</italic>-GlcNAc moieties. Furthermore, the heptamers <bold>20</bold>, <bold>26</bold>, <bold>31</bold>, <bold>35</bold>, <bold>38</bold> and <bold>40</bold> were transformed into the third set of GalN-, GalNAc and GlcN-containing heptamers <bold>53&#x2013;58</bold>. Similar to the first series, the silylidene groups were first removed. However, we then found that the TFA groups could not be cleaved even with strong basic/nucleophilic conditions and high temperatures (4M NaOH, 80&#xb0;C). Also attempts to remove the TFA groups&#x20;with the assistance of microwave failed (see experimental section, <xref ref-type="sec" rid="s9">Supplementary Table S1</xref>). A solution for this problem was found by first removing the benzyl ethers and concomitant reduction of the azido groups using hydrogenation over Pd(OH)<sub>2</sub>/C, followed by the temporary protection of the generated free amino groups with a Boc group. At this stage, the TFA groups could be removed with NH<sub>3</sub>
<sup>
<bold>.</bold>
</sup>H<sub>2</sub>O at 60&#xb0;C, after which acetylation of generated amines and subsequent removal of the Boc groups with 30% TFA provided the heptamers <bold>53&#x2013;58</bold> in 18&#x2013;31% yields. Although this sequence of reactions sacrificed the alkene group in the linker moiety it did grant access to the last series of Pel-oligosaccharides.</p>
<fig id="F3" position="float">
<label>SCHEME 1</label>
<caption>
<p>Deprotection of synthetic Pel heptasaccharides. a) i) HF/pyridine, THF, rt; ii) HS(CH<sub>2</sub>)<sub>3</sub>SH, Et<sub>3</sub>N, pyridine/H<sub>2</sub>O, rt. b) Na, NH<sub>3</sub> (liq.), THF, t-BuOH, 3-buten-1-ol, &#x2212;78&#xb0;C, yields for <bold>41</bold>: 69% (12/1 with:without C&#x3d;C); <bold>42</bold>: 48% (23/1); <bold>43</bold>: 84% (19/1); <bold>44</bold>: 53% (50/1); <bold>45</bold>: 59% (25/1); <bold>46</bold>: 85% (43/1). c) Ac<sub>2</sub>O, H<sub>2</sub>O, NaHCO<sub>3</sub>, rt, yields for <bold>47</bold>: 90%; <bold>48</bold>: 91% (11/1); <bold>49</bold>: 91% (32/1); <bold>50</bold>: 90% (32/1); <bold>51</bold>: 89% (21/1); <bold>52</bold>: 88% (12/1). d) i) HF/pyridine, THF, rt; ii) Pd(OH)<sub>2</sub>/C, H<sub>2</sub>, AcOH, THF/t-BuOH/H<sub>2</sub>O, rt; iii) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, H<sub>2</sub>O, rt; iv) NH<sub>3</sub>
<sup>
<bold>.</bold>
</sup>H<sub>2</sub>O, 60&#xb0;C; v) Ac<sub>2</sub>O, NaHCO<sub>3</sub>, H<sub>2</sub>O, rt; vi) 30% TFA in H<sub>2</sub>O, L &#x3d; (CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>, yields for <bold>53</bold>: 31%; <bold>54</bold>: 25%; <bold>55</bold>: 24%; <bold>56</bold>: 18%; <bold>57</bold>: 30%; <bold>58</bold>:&#x20;18%.</p>
</caption>
<graphic xlink:href="fchem-10-842238-g003.tif"/>
</fig>
</sec>
<sec sec-type="conclusion" id="s3">
<title>Conclusion</title>
<p>In conclusion, synthetic methodology enabling the assembly of Pel fragments has been developed. Key features of the synthetic strategy include the use of DTBS-directed <italic>&#x3b1;</italic>-glycosylation methodology and a regioselective benzylation procedure. The DTBS-directed glycosylation was not only successfully applied for the construction of <italic>&#x3b1;</italic>-GalN<sub>3</sub> and <italic>&#x3b1;</italic>-GalNTFA linkages, as already&#x20;previously described, it also proved applicable for the synthesis of&#x20;<italic>&#x3b1;</italic>-GlcN<sub>3</sub> linkages. With the increasing length of&#x20;the&#x20;oligosaccharides, the glycosylation yields decreased significantly, owing to the reduced nucleophilicity of the acceptors. Application of a reverse-addition-sequence strategy adequately improved the yields of the glycosylations providing the longer oligosaccharides in good yield. Six protected heptamers with different composition were subjected to different deprotection protocols, providing three sets of heptamers containing <italic>&#x3b1;</italic>-GlcN-<italic>&#x3b1;</italic>-GalN, <italic>&#x3b1;</italic>-GlcNAc-<italic>&#x3b1;</italic>-GalNAc and <italic>&#x3b1;</italic>-GlcN-<italic>&#x3b1;</italic>-GalNAc-<italic>&#x3b1;</italic>-GalN combinations. Unexpectedly, it proved impossible to remove the <italic>N</italic>-TFA groups in the heptamers carrying benzyl protecting groups. Fortunately, a protocol in which the benzyl and azide groups were first reduced, after which the liberated amines were temporarily masked as Boc-carbamates, allowed for removal of the TFA groups, using aqueous ammonia hydroxide. The synthetic Pel heptamers will be valuable for the define establishment of the&#x20;Pel structure, studies of the biosynthesis machinery and biofilm forming process as well as the development of vaccines and diagnostic tools to combat and monitor <italic>P. aeruginosa</italic> infections.</p>
</sec>
</body>
<back>
<sec id="s4">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s9">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>YZ and LW performed the experimental work. JC, GM, HO, LW, and YZ arranged and wrote the manuscript.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>This work was supported by the European Research Council (ERC-CoG-726072-&#x201c;GLYCONTROL&#x201d;, to J.D.C.C.).</p>
</sec>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2022.842238/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2022.842238/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bamford</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Le Mauff</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mill&#xe1;n</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Ega3 from the Fungal Pathogen Aspergillus fumigatus Is an Endo-<italic>&#x3b1;</italic>-1,4-Galactosaminidase that Disrupts Microbial Biofilms</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>294</volume> (<issue>37</issue>), <fpage>13833</fpage>&#x2013;<lpage>13849</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA119.009910</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bamford</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Le Mauff</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Van Loon</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Ostapska</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Snarr</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group>&#x20;(<year>2020</year>). <article-title>Structural and Biochemical Characterization of the Exopolysaccharide Deacetylase Agd3 Required for Aspergillus fumigatus Biofilm Formation</article-title>. <source>Nat. Commun.</source> <volume>11</volume> (<issue>1</issue>), <fpage>2450</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-16144-5</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benakli</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zha</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kerns</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Oxazolidinone Protected 2-Amino-2-Deoxy-D-Glucose Derivatives as Versatile Intermediates in Stereoselective Oligosaccharide Synthesis and the Formation of <italic>&#x3b1;</italic>-Linked Glycosides</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>123</volume> (<issue>38</issue>), <fpage>9461</fpage>&#x2013;<lpage>9462</lpage>. <pub-id pub-id-type="doi">10.1021/ja0162109</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Regioselective Alkylation of Carbohydrate Derivatives Catalyzed by a Diarylborinic Acid Derivative</article-title>. <source>Org. Lett.</source> <volume>13</volume> (<issue>12</issue>), <fpage>3090</fpage>&#x2013;<lpage>3093</lpage>. <pub-id pub-id-type="doi">10.1021/ol200990e</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colvin</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>V. D.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Borlee</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Wozniak</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>G. C. L.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>The Pel Polysaccharide Can Serve a Structural and Protective Role in the Biofilm Matrix of Pseudomonas aeruginosa</article-title>. <source>Plos. Pathog.</source> <volume>7</volume> (<issue>1</issue>), <fpage>e1001264</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1001264</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flo</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Latz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Monks</surname>
<given-names>B. G.</given-names>
</name>
<name>
<surname>Lien</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Involvement of Toll-like Receptor (TLR) 2 and TLR4 in Cell Activation by Mannuronic Acid Polymers</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>277</volume> (<issue>38</issue>), <fpage>35489</fpage>&#x2013;<lpage>35495</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M201366200</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franklin</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Nivens</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Weadge</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>P. L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl</article-title>. <source>Front. Microbio.</source> <volume>2</volume>, <fpage>167</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2011.00167</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.-H.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>X.-S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Pre-activation Protocol Leading to&#x20;Highly Stereoselectivity-Controllable Glycosylations of Oxazolidinone Protected Glucosamines</article-title>. <source>Chem. Commun.</source> (<issue>5</issue>), <fpage>597</fpage>&#x2013;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1039/b712591g</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghafoor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>I. D.</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>B. H. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Role of Exopolysaccharides in Pseudomonas aeruginosa Biofilm Formation and Architecture</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>77</volume> (<issue>15</issue>), <fpage>5238</fpage>&#x2013;<lpage>5246</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00637-11</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imamura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kiso</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Di-tert-butylsilylene-Directed <italic>&#x3b1;</italic>-Selective Synthesis of 4-Methylumbelliferyl T-Antigen</article-title>. <source>Org. Lett.</source> <volume>7</volume>, <fpage>4415</fpage>&#x2013;<lpage>4418</lpage>. <pub-id pub-id-type="doi">10.1021/ol051592z</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imamura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Korogi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Muraoka</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Di-tert-butylsilylene (DTBS) Group-Directed <italic>&#x3b1;</italic>-selective Galactosylation Unaffected by C-2 Participating Functionalities</article-title>. <source>Tetrahedron Lett.</source> <volume>44</volume> (<issue>35</issue>), <fpage>6725</fpage>&#x2013;<lpage>6728</lpage>. <pub-id pub-id-type="doi">10.1016/s0040-4039(03)01647-2</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imamura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matsuzawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Udagawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The Origin of High Stereoselectivity in Di-tert-butylsilylene-directed <italic>&#x3b1;</italic>-Galactosylation</article-title>. <source>J.&#x20;Org. Chem.</source> <volume>81</volume> (<issue>19</issue>), <fpage>9086</fpage>&#x2013;<lpage>9104</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.6b01685</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingle</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>C.-S.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>W.-C.</given-names>
</name>
<name>
<surname>Mong</surname>
<given-names>K.-K. T.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Tuning Reactivity of Glycosyl Imidinium Intermediate for 2-Azido-2-Deoxyglycosyl Donors in <italic>&#x3b1;</italic>-Glycosidic Bond Formation</article-title>. <source>Org. Lett.</source> <volume>15</volume> (<issue>20</issue>), <fpage>5290</fpage>&#x2013;<lpage>5293</lpage>. <pub-id pub-id-type="doi">10.1021/ol402519c</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jackson</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Starkey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kremer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Parsek</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Wozniak</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Identification of Psl , a Locus Encoding a Potential Exopolysaccharide that Is Essential for Pseudomonas aeruginosa PAO1 Biofilm Formation</article-title>. <source>J.&#x20;Bacteriol.</source> <volume>186</volume> (<issue>14</issue>), <fpage>4466</fpage>&#x2013;<lpage>4475</lpage>. <pub-id pub-id-type="doi">10.1128/JB.186.14.4466-4475.2004</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jennings</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Storek</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Ledvina</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Coulon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Marmont</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Sadovskaya</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Pel Is a Cationic Exopolysaccharide that Cross-Links Extracellular DNA in thePseudomonas Aeruginosabiofilm Matrix</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>112</volume> (<issue>36</issue>), <fpage>11353</fpage>&#x2013;<lpage>11358</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1503058112</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazakova</surname>
<given-names>E. D.</given-names>
</name>
<name>
<surname>Yashunsky</surname>
<given-names>D. V.</given-names>
</name>
<name>
<surname>Krylov</surname>
<given-names>V. B.</given-names>
</name>
<name>
<surname>Bouchara</surname>
<given-names>J.-P.</given-names>
</name>
<name>
<surname>Cornet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Valsecchi</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Biotinylated Oligo-<italic>&#x3b1;</italic>-(1 &#x2192; 4)-D-Galactosamines and Their N-Acetylated Derivatives: <italic>&#x3b1;</italic>-Stereoselective Synthesis and Immunology Application</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>142</volume> (<issue>3</issue>), <fpage>1175</fpage>&#x2013;<lpage>1179</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.9b11703</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Mauff</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bamford</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Alnabelseya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Molecular Mechanism of Aspergillus fumigatus Biofilm Disruption by Fungal and Bacterial Glycoside Hydrolases</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>294</volume> (<issue>28</issue>), <fpage>10760</fpage>&#x2013;<lpage>10772</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA119.008511</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Borinic Acid-Catalyzed Regioselective Acylation of Carbohydrate Derivatives</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>133</volume> (<issue>11</issue>), <fpage>3724</fpage>&#x2013;<lpage>3727</lpage>. <pub-id pub-id-type="doi">10.1021/ja110332r</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Regioselective, Borinic Acid-Catalyzed Monoacylation, Sulfonylation and Alkylation of Diols and Carbohydrates: Expansion of Substrate Scope and Mechanistic Studies</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>134</volume> (<issue>19</issue>), <fpage>8260</fpage>&#x2013;<lpage>8267</lpage>. <pub-id pub-id-type="doi">10.1021/ja302549c</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Parsek</surname>
<given-names>M. R.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Synthesis of Multiple Pseudomonas aeruginosa Biofilm Matrix Exopolysaccharides Is post-transcriptionally Regulated</article-title>. <source>Environ. Microbiol.</source> <volume>14</volume> (<issue>8</issue>), <fpage>1995</fpage>&#x2013;<lpage>2005</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-2920.2012.02753.x</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manabe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>N-Benzyl-2,3-oxazolidinone as a Glycosyl Donor for Selective <italic>&#x3b1;</italic>-Glycosylation and One-Pot Oligosaccharide Synthesis Involving 1,2-Cis-Glycosylation</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>128</volume> (<issue>33</issue>), <fpage>10666</fpage>&#x2013;<lpage>10667</lpage>. <pub-id pub-id-type="doi">10.1021/ja062531e</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marmont</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Whitfield</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Giesbrecht</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Stremick</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>PelA and PelB Proteins Form a Modification and Secretion Complex Essential for Pel Polysaccharide-dependent Biofilm Formation in Pseudomonas aeruginosa</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>292</volume> (<issue>47</issue>), <fpage>19411</fpage>&#x2013;<lpage>19422</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.812842</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mensah</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Nickel-Catalyzed Stereoselective Glycosylation with C(2)-N-Substituted Benzylidene D-Glucosamine and Galactosamine Trichloroacetimidates for the Formation of 1,2-Cis-2-Amino Glycosides. Applications to the Synthesis of Heparin Disaccharides, GPI Anchor Pseudodisaccharides, and <italic>&#x3b1;</italic>-GalNAc</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>132</volume> (<issue>40</issue>), <fpage>14288</fpage>&#x2013;<lpage>14302</lpage>. <pub-id pub-id-type="doi">10.1021/ja106682m</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olsson</surname>
<given-names>J.&#x20;D. M.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lahmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oscarson</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Investigations of Glycosylation Reactions with 2-N-Acetyl-2n,3o-Oxazolidinone-Protected Glucosamine Donors</article-title>. <source>J.&#x20;Org. Chem.</source> <volume>73</volume> (<issue>18</issue>), <fpage>7181</fpage>&#x2013;<lpage>7188</lpage>. <pub-id pub-id-type="doi">10.1021/jo800971s</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kawatkar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Boons</surname>
<given-names>G.-J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Stereoselective Glycosylations of 2-Azido-2-Deoxy-Glucosides Using Intermediate Sulfonium Ions</article-title>. <source>Org. Lett.</source> <volume>9</volume> (<issue>10</issue>), <fpage>1959</fpage>&#x2013;<lpage>1962</lpage>. <pub-id pub-id-type="doi">10.1021/ol070513b</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Revuelta</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fuentes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lagartera</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hern&#xe1;iz</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Bastida</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Junceda</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Assembly of Glycoamino Acid Building Blocks: a New Strategy for the Straightforward Synthesis of Heparan Sulfate Mimics</article-title>. <source>Chem. Commun.</source> <volume>54</volume> (<issue>95</issue>), <fpage>13455</fpage>&#x2013;<lpage>13458</lpage>. <pub-id pub-id-type="doi">10.1039/C8CC08067D</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Imamura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kiso</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Di-tert-butylsilylene-directed <italic>&#x3b1;</italic>-selective Synthesis of P-Nitrophenyl T-Antigen Analogues</article-title>. <source>Glycoconj.&#x20;J.</source> <volume>26</volume> (<issue>1</issue>), <fpage>83</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1007/s10719-008-9168-y</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Vorm</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Overkleeft</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>van der Marel</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Cod&#xe9;e</surname>
<given-names>J.&#x20;D. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Stereoselectivity of Conformationally Restricted Glucosazide Donors</article-title>. <source>J.&#x20;Org. Chem.</source> <volume>82</volume> (<issue>9</issue>), <fpage>4793</fpage>&#x2013;<lpage>4811</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.7b00470</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Overkleeft</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>van der Marel</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Cod&#xe9;e</surname>
<given-names>J.&#x20;D. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Reagent Controlled Stereoselective Synthesis of <italic>&#x3b1;</italic>-Glucans</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>140</volume> (<issue>13</issue>), <fpage>4632</fpage>&#x2013;<lpage>4638</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.8b00669</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Overkleeft</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>van der Marel</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Cod&#xe9;e</surname>
<given-names>J.&#x20;D. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Reagent Controlled Glycosylations for the Assembly of Well-Defined Pel Oligosaccharides</article-title>. <source>J.&#x20;Org. Chem.</source> <volume>85</volume> (<issue>24</issue>), <fpage>15872</fpage>&#x2013;<lpage>15884</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.0c00703</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kerns</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Factors Affecting Stereocontrol during Glycosidation of 2,3-Oxazolidinone-Protected 1-Tolylthio-N-Acetyl-D-Glucosamine</article-title>. <source>J.&#x20;Org. Chem.</source> <volume>70</volume> (<issue>10</issue>), <fpage>4195</fpage>&#x2013;<lpage>4198</lpage>. <pub-id pub-id-type="doi">10.1021/jo047812o</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitfield</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Marmont</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Ostaszewski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Whitney</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Parsek</surname>
<given-names>M. R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Pel Polysaccharide Biosynthesis Requires an Inner Membrane Complex Comprised of PelD, PelE, PelF, and PelG</article-title>. <source>J.&#x20;Bacteriol.</source> <volume>202</volume> (<issue>8</issue>). <pub-id pub-id-type="doi">10.1128/JB.00684-19</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>X.-S.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Additive-Controlled Stereoselective Glycosylations of Oxazolidinone-Protected Glucosamine and Galactosamine Thioglycoside Donors Based on Preactivation Protocol</article-title>. <source>Synlett</source> <volume>2010</volume> (<issue>16</issue>), <fpage>2506</fpage>&#x2013;<lpage>2512</lpage>. <pub-id pub-id-type="doi">10.1055/s-0030-1258557</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gimeno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Santana</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Vald&#xe9;s-Balbin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Noda</surname>
<given-names>L. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody Interaction</article-title>. <source>ACS Cent. Sci.</source> <volume>5</volume> (<issue>8</issue>), <fpage>1407</fpage>&#x2013;<lpage>1416</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.9b00454</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>G&#xf3;mez&#x2010;Redondo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jim&#xe9;nez&#x2010;Os&#xe9;s</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Overkleeft</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Marel</surname>
<given-names>G. A.</given-names>
</name>
<etal/>
</person-group> (<year>2020a</year>). <article-title>Synthesis and Structural Analysis of Aspergillus fumigatus Galactosaminogalactans Featuring <italic>&#x3b1;</italic>&#x2010;Galactose, <italic>&#x3b1;</italic>&#x2010;Galactosamine and <italic>&#x3b1;</italic>&#x2010; N &#x2010;Acetyl Galactosamine Linkages</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>59</volume> (<issue>31</issue>), <fpage>12746</fpage>&#x2013;<lpage>12750</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202003951</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020b</year>). <article-title>Efficient Strategy for <italic>&#x3b1;</italic>-Selective Glycosidation of D-Glucosamine and its Application to the Synthesis of a Bacterial Capsular Polysaccharide Repeating Unit Containing Multiple <italic>&#x3b1;</italic>-Linked GlcNAc Residues</article-title>. <source>Org. Lett.</source> <volume>22</volume> (<issue>4</issue>), <fpage>1520</fpage>&#x2013;<lpage>1524</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.0c00101</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>